Healthcare Innovation and Venture Capital with Brian Armstrong of Ensemble Innovation Ventures

Highlights

• Ensemble Innovation Ventures focuses exclusively on health tech and tech-enabled services, targeting Series A and seed-stage companies.
• The fund operates as a hybrid corporate venture capital with a single limited partner, maintaining traditional venture governance structures.
• Investment decisions prioritize financial returns, healthcare impact (access, cost, outcomes), and strategic alignment with their operating company.
• Ensemble emphasizes co-investing with strong syndicates and cultivating authentic relationships with founders and investors.
• The fund is geographically agnostic across the U.S., investing wherever compelling health tech solutions exist.
• AI is integrated into Ensemble’s internal processes for meeting transcription, pipeline management, and enhancing diligence efficiency.
• Authenticity is viewed as a core value in venture investing, critical for relationship-building and long-term success.

---

Summary

In this episode of The Innovators and Investors Podcast, host Kristian Marquez interviews Brian Armstrong, Managing Director of Ensemble Innovation Ventures, a specialized venture fund focused on health tech and tech-enabled services in healthcare. Brian discusses Ensemble’s investment thesis, fund structure, approach to deal sourcing, and the impact of AI on venture capital operations. Ensemble targets Series A and seed-stage companies delivering software and service innovations that improve healthcare outcomes, access, and cost efficiency. The fund operates as a hybrid corporate venture capital entity with a single limited partner, emphasizing financial returns while valuing healthcare impact and strategic alignment. Brian highlights the significance of authenticity in venture investing, the evolving dynamics of the venture ecosystem amid economic uncertainty and technological advancements, and the critical role of advisory networks in managing sector expertise. He also shares insights into his personal journey into venture capital, the importance of diversification in the portfolio, and the anticipation of transformative changes in venture over the next five years. The conversation closes with reflections on mentorship’s influence and encouragement for founders and investors to maintain mission-driven authenticity.

Key Insights

• Hybrid Corporate Venture Capital Model Enables Flexibility and Discipline: Ensemble Innovation Ventures is structured as a hybrid corporate venture fund with a single limited partner and traditional governance, blending the strategic benefits of corporate backing with the discipline of traditional venture investing. This model allows for clear capital deployment timelines and decision-making guardrails while enabling flexible pursuit of financial, healthcare impact, and strategic objectives. This hybrid approach can serve as a model for other corporate ventures seeking to balance multiple outcomes without compromising on fund governance or operational rigor.
• Healthcare Impact as a Core Investment Criterion Beyond Financial Returns: While financial returns remain foundational, Ensemble places strong emphasis on generating meaningful healthcare impact through innovation—specifically improving access, reducing costs, and enhancing outcomes. This dual mandate reflects a growing trend in venture capital where mission-driven investing aligns with commercial success, particularly in sectors like healthcare where societal benefits are measurable and critical. This approach encourages portfolio companies to innovate responsibly and with purpose, ensuring capital deployment supports systemic improvements.
• Syndicate-Driven Deal Flow and Authentic Relationship Cultivation: Ensemble’s deal sourcing strategy is heavily reliant on co-investor networks and syndicates, valuing “who we co-invest with as much as who we invest in.” This underscores the importance of credibility and trust within the healthcare venture ecosystem, where partnerships with like-minded investors help validate deal quality and provide operational support. Additionally, Ensemble’s proactive outbound engagement with early-stage founders builds a long-term pipeline, enabling informed investment timing and deeper due diligence. This dual inbound/outbound sourcing model is essential in healthcare, where early proof of concept and clinical validation can be regionally focused before scaling.
• Geographic Agnosticism to Maximize Innovation Reach: Ensemble adopts a nationwide investment approach, reflecting the decentralized nature of healthcare innovation in the U.S. Founders often initially commercialize regionally due to localized healthcare networks, but Ensemble’s willingness to invest broadly enables them to capture promising innovations regardless of geography. This is particularly important in healthcare tech, where solutions can emerge in diverse markets and require regional proof points before scaling nationally. The only gap noted is in the Southeast, where Ensemble is actively building syndicate relationships to unlock opportunities.
• Integration of AI as a Force Multiplier in Venture Operations: Ensemble has begun leveraging AI tools internally to enhance productivity through automated meeting transcription, conversation analysis, and pipeline management. They are exploring AI use in diligence to accelerate deal evaluation without compromising quality. This reflects a broader industry shift toward data-driven venture models that can process increasing deal flow volumes and complexity efficiently. The anticipated expansion of AI’s role over the next five years signals a fundamental transformation in how venture firms operate, making them more agile and informed while potentially reducing the need for larger teams.
• Venture Capital in a Period of Unprecedented Uncertainty and Transformation: Brian highlights the venture landscape as the most unpredictable era since its institutionalization, shaped by economic volatility, geopolitical uncertainty, inflation, and rapid technological change, especially AI. The industry is experiencing shifts such as established funds winding down and an increase in smaller emerging funds, which alters syndication dynamics. Despite these challenges, innovation continues to find ways to thrive, with venture adapting its evaluation frameworks and strategic approaches accordingly. This period demands heightened flexibility and continuous learning for investors and founders alike.
• Authenticity as a Foundational Value for Long-Term Success: Brian emphasizes that authenticity—in relationships, work ethic, and intent—is critical in venture capital. Authenticity facilitates trust, eases the inherent difficulties of the asset class, and fosters sustainable partnerships between investors, founders, and co-investors. Both investors and founders face dramatic highs and lows, and navigating these with genuine engagement improves resilience and outcomes. This insight serves as a reminder that beyond financial metrics, human factors and integrity remain central to venture success.

Additional Observations

• Ensemble’s strategy of diversification across company types, customer segments, and syndicate partners mitigates concentration risk and enhances portfolio resilience.
• The fund’s reliance on an advisory group and holding company board supplements the small internal team’s healthcare expertise, ensuring industry developments and investment opportunities are closely monitored.
• Brian’s personal narrative reflects a deep passion for venture investing rooted in early experiences with founder studios/incubators, highlighting the importance of supporting founders beyond capital with operational and strategic guidance.
• The conversation underscores the evolving role of venture capital from purely financial backers to active partners engaging in mission-driven innovation, especially in sectors like healthcare with complex ecosystems and regulatory environments.

Overall, this episode provides a comprehensive look into how a focused healthcare venture fund operates amid a rapidly changing venture landscape, balancing financial discipline, impact orientation, and technological innovation to drive meaningful progress in healthcare.

Stay up-to-date with Brian Armstrong and his work with Ensemble Innovation Ventures.

Follow our show on your podcast channel of choice or listen below.